Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Pediatr Infect Dis J ; 15(4): 298-303, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8866797

RESUMO

BACKGROUND: Cerebrospinal fluid (CSF) values in the noninfected neonate are not well-delineated. Studies analyzing these values are inconsistent in the criteria used to define the noninfected population. The purpose of our study was to examine CSF values in neonates in the first 30 days of life in whom infection was more thoroughly excluded than in previous reports. Stringent inclusion criteria defined the noninfected population, and the recently available polymerase chain reaction (PCR) for enteroviruses was used in addition to cultures to help exclude viral disease. Results were also stratified by age in weeks to evaluate for any variability that occurs in CSF values during the first month of life. METHODS: Neonates were selected from subjects enrolled in two studies on aseptic meningitis. Noninfected infants were identified by the following criteria: (1) atraumatic lumbar puncture (< or = 1000 red blood cells/mm3); (2) no antibiotic therapy before lumbar puncture; (3) sterile blood, CSF and urine bacterial cultures; (4) negative CSF viral culture; and (5) negative CSF PCR for enteroviruses. RESULTS: The mean +/- SD total CSF white blood cell count for 108 noninfected neonates was 7.3 +/- 14/mm3 (95% confidence interval 6.6 to 8.0/mm3) with a median of 4/mm3 and a range of 0 to 130/mm3. There were no significant differences in the mean CSF white blood cell counts among age categories. CONCLUSIONS: The application of stringent inclusion criteria and the use of the PCR yielded a population of infants that better represents the noninfected neonate than earlier reports. These values can be used for reference in evaluating the febrile or ill neonate.


Assuntos
Líquido Cefalorraquidiano/química , Fatores Etários , Infecções Bacterianas/diagnóstico , Líquido Cefalorraquidiano/microbiologia , Líquido Cefalorraquidiano/virologia , Glucose/análise , Humanos , Recém-Nascido , Contagem de Leucócitos , Neutrófilos , Reação em Cadeia da Polimerase , Proteínas/análise , Viroses/diagnóstico
3.
J Infect Dis ; 171(1): 161-9, 1995 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7798656

RESUMO

Intracisternal or intraarticular inoculation of rabbit recombinant interleukin (IL)-1 beta and rabbit tumor necrosis factor-alpha combined with IL-1 receptor antagonist (IL-1RA) and soluble tumor necrosis factor receptor (sTNFR), respectively, produced significantly less inflammation in rabbits than after inoculation of these cytokines alone. In contrast, when Haemophilus influenzae type b (Hib) or Hib lipooligosaccharide (LOS) was given intraarticularly with IL-1RA, sTNFR, or the combination, there was no significant or consistent modulation of synovial inflammation and cartilage proteoglycan degradation. In the experimental meningitis model, IL-1RA and sTNFR did not significantly reduce the meningeal inflammatory response associated with intracisternal inoculation of Hib LOS. These data indicate that specific cytokine inhibitors (sTNFR and IL-1RA) may not be effective in modulating inflammation induced by a broad inflammatory stimulus such as gram-negative bacteria or their products and suggest caution in using them to treat these infectious conditions in humans.


Assuntos
Artrite Infecciosa/tratamento farmacológico , Infecções por Haemophilus/tratamento farmacológico , Haemophilus influenzae , Meningite por Haemophilus/tratamento farmacológico , Receptores do Fator de Necrose Tumoral , Sialoglicoproteínas/uso terapêutico , Animais , Edema Encefálico/tratamento farmacológico , Proteínas do Líquido Cefalorraquidiano/análise , Humanos , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1/farmacologia , Sulfato de Queratano/análise , Lactatos/líquido cefalorraquidiano , Ácido Láctico , Contagem de Leucócitos , Lipopolissacarídeos/toxicidade , Masculino , Coelhos , Solubilidade , Líquido Sinovial/química , Fator de Necrose Tumoral alfa/farmacologia
4.
Antimicrob Agents Chemother ; 38(1): 83-9, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7511361

RESUMO

To assess the effects of antifungal therapy on the course of Candida albicans central nervous system infection and inflammation, we inoculated intracisternally 10(5) CFU of C. albicans into rabbits. Fluconazole (10 mg/kg of body weight) or amphotericin B (1 mg/kg) was infused intravenously daily for 14 days. Treatment was initiated 24 h or 5 days after infection. Cerebrospinal fluid (CSF) was repeatedly obtained to culture the organisms, assess the level of inflammation, and measure drug concentrations. Brain tissue was obtained at the end of therapy for culture, drug concentration determinations, and histopathology. The median number of days of treatment required to sterilize CSF cultures was 4 days for fluconazole therapy and 1 day for amphotericin B therapy (P = 0.037). There was a significant reduction in tumor necrosis factor alpha and leukocyte concentrations in the CSF of animals treated early versus those in untreated control animals (P < 0.05 and P < 0.001, respectively; analysis of variance). Compared with treated animals, a higher proportion of cultured CSF samples from untreated animals were positive for Candida (P < 0.001). A cultured brain sample from 1 of the 12 animals treated early with amphotericin B was positive for C. albicans (P < 0.01 versus controls); cultures of brain samples from 3 of 12 animals treated early with fluconazole were positive, whereas cultures of brain samples from 10 of 12 controls were positive (P < 0.05). The mean density of C. albicans was lower in the single culture-positive amphotericin B recipient (1 x 10(1) CFU/g of brain tissue) than in those treated with fluconazole (1 x 10(3) CFU/g) and in controls (8 x 10(4) CFU/g). In animals treated late, the density of C. albicans in the brain in relation to the number of days of therapy was significantly lower in amphotericin B recipients than in those treated with fluconazole (P < 0.01) and untreated controls (P < 0.01; analysis of covariance). By histopathology, a larger proportion of untreated animals compared with those treated early demonstrated features of severe infection such as perivasculitis, ventriculitis, and evidence of fungal organisms. Compared with amphotericin B-treated rabbits, those given fluconazole had a trend toward more severe pathologic lesions. Reduced susceptibility to both fluconazole and amphotericin B was observed in the C. albicans organisms isolated from the brain of one fluconazole-treated animal. These data suggest that amphotericin B is the preferred treatment for C. albicans infections of the central nervous system.


Assuntos
Antifúngicos/uso terapêutico , Candidíase/tratamento farmacológico , Meningite Fúngica/tratamento farmacológico , Anfotericina B/uso terapêutico , Animais , Antifúngicos/farmacocinética , Antifúngicos/farmacologia , Encéfalo/microbiologia , Candida albicans/efeitos dos fármacos , Candidíase/microbiologia , Candidíase/patologia , Citocinas/líquido cefalorraquidiano , Fluconazol/uso terapêutico , Inflamação/patologia , Interferons/sangue , Contagem de Leucócitos , Masculino , Meningite Fúngica/microbiologia , Meningite Fúngica/patologia , Testes de Sensibilidade Microbiana , Coelhos , Fator de Necrose Tumoral alfa/líquido cefalorraquidiano
5.
J Infect Dis ; 168(5): 1186-93, 1993 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7901286

RESUMO

The role of cytokines in the regulation of articular inflammation and cartilage degradation was evaluated in the rabbit model of Haemophilus influenzae type b arthritis. At 6 and 12 h after intraarticular infection, treatment with IB4 monoclonal antibody to the CD18 leukocyte receptor alone or in combination with dexamethasone resulted in significant reduction of synovial fluid (SF) neutrophil concentration. Treatment with dexamethasone alone was associated with lower SF concentrations of interleukin-1 (IL-1), tumor necrosis factor-alpha, and stromelysin than in other groups. At 24 h after infection, increased cartilage degradation was detected in untreated controls and in animals treated with IB4 alone or in combination with dexamethasone compared with those treated with dexamethasone alone. Multiple regression analyses indicated SF concentration of IL-1 and stromelysin as the significant predictors of cartilage degradation. These data suggest that IL-1 mediates cartilage degradation by regulation of metalloproteinases, such as stromelysin, during acute experimental bacterial arthritis.


Assuntos
Artrite Infecciosa/tratamento farmacológico , Cartilagem Articular/metabolismo , Citocinas/metabolismo , Dexametasona/uso terapêutico , Infecções por Haemophilus/tratamento farmacológico , Haemophilus influenzae , Animais , Anticorpos Monoclonais/uso terapêutico , Antígenos CD/imunologia , Antígenos CD18 , Cartilagem Articular/patologia , Ceftriaxona/farmacologia , Inflamação/patologia , Injeções Intra-Articulares , Interleucina-1/análise , Masculino , Metaloproteinase 3 da Matriz , Metaloendopeptidases/análise , Neutrófilos/citologia , Proteoglicanas/metabolismo , Coelhos , Análise de Regressão , Líquido Sinovial/química , Líquido Sinovial/citologia , Líquido Sinovial/microbiologia , Membrana Sinovial/patologia , Fator de Necrose Tumoral alfa/análise
6.
J Infect Dis ; 168(3): 657-62, 1993 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8354907

RESUMO

In a rabbit Escherichia coli meningitis model, endotoxin liberation and concentrations of leukocytes, tumor necrosis factor (TNF), and lactate were compared after a single intravenous dose of cefotaxime, cefpirome, meropenem, chloramphenicol, or gentamicin. These antibiotics caused a 2- to 10-fold increase in cerebrospinal fluid concentrations of free (filterable) endotoxin within 2 h of starting treatment. By contrast, free endotoxin concentrations increased almost 100-fold in untreated animals 4 h later as bacteria continued to multiply. An initial enhancement of inflammation in the central nervous system occurred in all treatment groups compared with untreated controls. No significant differences were observed between treatment groups except for lower TNF concentrations in chloramphenicol-treated animals. Antibiotic therapy in E. coli meningitis, irrespective of the agent used, may result in an increase in free endotoxin and enhancement of inflammation, but the amount of endotoxin liberated is considerably smaller than that shed by untreated bacteria.


Assuntos
Antibacterianos/farmacologia , Endotoxinas/líquido cefalorraquidiano , Infecções por Escherichia coli/metabolismo , Inflamação/metabolismo , Meningites Bacterianas/metabolismo , Animais , Cefotaxima/farmacologia , Cefalosporinas/farmacologia , Cloranfenicol/farmacologia , Infecções por Escherichia coli/tratamento farmacológico , Gentamicinas/farmacologia , Masculino , Meningites Bacterianas/tratamento farmacológico , Meropeném , Coelhos , Tienamicinas/farmacologia , Cefpiroma
7.
Antimicrob Agents Chemother ; 37(8): 1630-6, 1993 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8215275

RESUMO

The most appropriate therapy for meningitis caused by Streptococcus pneumoniae strains resistant to the extended-spectrum cephalosporins is unknown. We evaluated ceftriaxone, vancomycin, and rifampin alone and in different combinations and meropenem, cefpirome, and clinafloxacin alone in the rabbit meningitis model. Meningitis was induced in rabbits by intracisternal inoculation of one of two pneumococcal strains isolated from infants with meningitis (ceftriaxone MICs, 4 and 1 microgram/ml, respectively). Two doses, 5 h apart, of each antibiotic were given intravenously (except that ceftriaxone was given as one dose). Cerebrospinal fluid bacterial concentrations were measured at 0, 5, 10, and 24 h after therapy was started. Clinafloxacin was the most active single agent against both strains. Against the more resistant strain, ceftriaxone or meropenem alone was ineffective. The combination of vancomycin and ceftriaxone was synergistic, suggesting that this combination might be effective for initial empiric therapy of pneumococcal meningitis until results of susceptibility studies are available.


Assuntos
Antibacterianos/farmacologia , Cefalosporinas/farmacologia , Fluoroquinolonas , Meningite Pneumocócica/tratamento farmacológico , Resistência às Penicilinas , Animais , Anti-Infecciosos/farmacologia , Ceftriaxona/farmacologia , Modelos Animais de Doenças , Resistência Microbiana a Medicamentos , Sinergismo Farmacológico , Quimioterapia Combinada/farmacologia , Masculino , Meropeném , Testes de Sensibilidade Microbiana , Quinolonas/farmacologia , Coelhos , Rifampina/farmacologia , Tienamicinas/farmacologia , Vancomicina/farmacologia , Cefpiroma
8.
Pediatr Infect Dis J ; 12(3): 196-200, 1993 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8451095

RESUMO

We recently managed an infant with meningitis caused by Streptococcus pneumoniae in whom ceftriaxone failed to sterilize the cerebrospinal fluid after 6 days of therapy. This strain, which had a penicillin minimal inhibitory concentration (MIC) of 2 micrograms/ml, appeared susceptible to ceftriaxone (MIC < 0.5 micrograms/ml) when evaluated by a commercial MIC panel (Microtech Medical Systems, Inc., Aurora, CO) but was found to have a ceftriaxone MIC of 4 micrograms/ml when evaluated by conventional microtiter broth dilution technique. Furthermore ceftriaxone therapy of meningitis induced with this strain in a rabbit model was ineffective. Thirteen of 112 pneumococcal strains (11.6%) isolated recently at Children's Medical Center of Dallas were penicillin-resistant, and 3 of these were highly penicillin-resistant (MIC > or = 2 micrograms/ml). The incidence of pneumococcal strains with cefotaxime MICs > or = 1.0 micrograms/ml has increased from 0 of 258 from 1981 to 1983 to 5 of 112 (4.5%) from 1991 to 1992. The definition of cephalosporin resistance for pneumococci requires modification and further studies of the antibiotic management of meningitis caused by such strains are needed because resistance to cephalosporins is increasing and the extended spectrum cephalosporins may be ineffective as sole therapy.


Assuntos
Cefalosporinas/farmacologia , Meningite Pneumocócica/diagnóstico , Meningite Pneumocócica/tratamento farmacológico , Streptococcus pneumoniae/efeitos dos fármacos , Animais , Modelos Animais de Doenças , Resistência Microbiana a Medicamentos , Humanos , Lactente , Masculino , Meningite Pneumocócica/líquido cefalorraquidiano , Testes de Sensibilidade Microbiana , Resistência às Penicilinas , Coelhos , Streptococcus pneumoniae/fisiologia
9.
Phys Ther ; 68(4): 534-40, 1988 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3353463

RESUMO

The purposes of this study were 1) to discover the extent to which craniosacral therapy (CST) and myofascial release (MFR) instruction are included in entry-level physical therapy curricula; 2) to determine the amount of faculty and program director interest in such instruction; and 3) to determine what educational materials, if any, are desired. A one-page questionnaire was distributed to the program directors of 109 accredited entry-level physical therapy programs in the United States. Of the 95 respondents, 1 (1%) included a unit on CST only, 14 (15%) included a unit on MFR only, 14 (15%) included units on both CST and MFR, and 66 (69%) included neither. The highest percentages of programs with CST and MFR units were entry-level masters' degree programs and programs located in the Pacific Coast and Middle Atlantic regions. All of the units were presented within required courses, usually during the second year; most were taught by physical therapists. The greatest amount of instructional time was allotted for CST laboratory sessions (mean = 5.8 hours), and the least amount of time was allotted for MFR lectures (mean = 1.7 hours). The mos frequently cited reason for noninclusion of CST or MFR instruction was inadequate room in the current curricula. The most frequently requested materials were bibliographies and laboratory guides on CST and MFR. Implications of these findings are addressed, and suggestions for further research are given.


Assuntos
Currículo , Modalidades de Fisioterapia/educação , Sistema Nervoso Central/fisiologia , Fáscia/fisiologia , Humanos , Músculos/fisiologia , Modalidades de Fisioterapia/métodos , Inquéritos e Questionários , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...